Clinical trial
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
NCT00559936 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- October 31, 2010
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.